Jozsef Szasz
Jozsef Szasz
Verified email at umftgm.ro
Title
Cited by
Cited by
Year
Randomized trial of safinamide add‐on to levodopa in Parkinson's disease with motor fluctuations
R Borgohain, J Szasz, P Stanzione, C Meshram, M Bhatt, D Chirilineau, ...
Movement Disorders 29 (2), 229-237, 2014
1912014
Two‐year, randomized, controlled study of safinamide as add‐on to levodopa in mid to late Parkinson's disease
R Borgohain, J Szasz, P Stanzione, C Meshram, MH Bhatt, D Chirilineau, ...
Movement Disorders 29 (10), 1273-1280, 2014
1752014
Factors influencing hemorrhagic transformation in ischemic stroke: a clinicopathological comparison
L Kerenyi, L Kardos, J Szász, S Szatmári, D Bereczki, K Hegedüs, L Csiba
European journal of neurology 13 (11), 1251-1255, 2006
1042006
Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry
A Antonini, W Poewe, KR Chaudhuri, R Jech, B Pickut, Z Pirtošek, J Szasz, ...
Parkinsonism & related disorders 45, 13-20, 2017
862017
The effect of levodopa–carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson’s disease: a multicenter Romanian experience
O Băjenaru, A Ene, BO Popescu, JA Szasz, M Sabău, DF Mureşan, ...
Journal of Neural Transmission 123 (4), 407-414, 2016
372016
Prestroke alcohol consumption and smoking are not associated with stroke severity, disability at discharge, and case fatality
K Fekete, S Szatmári, I Szőcs, C Szekeres, J Szász, L Mihálka, ...
Journal of Stroke and Cerebrovascular Diseases 23 (1), e31-e37, 2014
252014
The role of selective monoamine oxidase B inhibitors in the therapeutic strategy of Parkinson's disease in the neurology clinics of Tirgu Mures County Emergency Clinical Hospital
JA Szász, V Constantin, PA Fazakas, E Blényesi, LG Grieb, A Balla, ...
Orvosi hetilap 158 (51), 2023-2028, 2017
102017
Therapeutic strategies in the early stages of Parkinson’s disease: a cross-sectional evaluation of 15 years’ experience with a large cohort of Romanian patients
JA Szász, K Orbán-Kis, VA Constantin, C Péter, I Bíró, I Mihály, K Szegedi, ...
Neuropsychiatric disease and treatment 15, 831, 2019
82019
The Mureş–Uzhgorod–Debrecen study: a comparison of hospital stroke services in Central‐Eastern Europe
S Szatmári, I Pascu, L Mihálka, SV Mulesa, I Fekete, B Fülesdi, L Csiba, ...
European journal of neurology 9 (3), 293-296, 2002
82002
Dopamine agonists in Parkinson's disease therapy-15 years of experience of the Neurological Clinics from Tîrgu Mureș. A cross-sectional study
JA Szász, C Viorelia, I Mihály, I Biró, C Péter, K Orbán-Kis, S Szatmári
Ideggyogyaszati szemle 72 (5-6), 187-193, 2019
72019
Characteristics of levodopa treatment in advanced Parkinson's disease in the experiences of the neurology clinics of Târgu Mureș, Romania
JA Szász, S Szatmári, V Constantin, I Mihály, A Rácz, LC Domokos, ...
Orvosi hetilap 160 (17), 662-669, 2019
72019
Levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients: Final long-term non-motor, quality of life and safety results from the GLORIA …
K Chaudhuri, Z Pirtosek, B Pickut, W Poewe, F Valldeoriola, L Defebvre, ...
Movement Disorders 31, 2016
72016
First 2-year, controlled study to assess safinamide as add-on to levodopa in Parkinson's disease with motor fluctuations: 361
R Borgohain, J Szasz, P Stanzione, C Meshram, M Bhatt, F Stocchi, ...
Movement Disorders 26, 2011
72011
Levodopa-Carbidopa Intestinal Gel Infusion Therapy Discontinuation: A Ten-Year Retrospective Analysis of 204 Treated Patients
VA Constantin, JA Szász, K Orbán-Kis, EC Rosca, M Popovici, A Cornea, ...
Neuropsychiatric Disease and Treatment 16, 1835, 2020
62020
Profile of patients with advanced Parkinson’s disease suitable for device-aided therapies: restrospective data of a large cohort of Romanian patients
JA Szász, VA Constantin, K Orbán-Kis, A Rácz, LA Bancu, D Georgescu, ...
Neuropsychiatric disease and treatment 15, 3187, 2019
62019
Characteristics of dopaminergic treatments in advanced Parkinson's before levodopa-carbidopa intestinal gel infusion: Data from 107 tested patients
J Szász, V Constantin, K Orbán-Kis, L Bancu, D Georgescu, J Szederjesi, ...
MOVEMENT DISORDERS 33, S171-S171, 2018
62018
Efficacy and safety of safinamide in patients with Parkinson's disease experiencing motor fluctuations: results of a 6-month Phase III, randomized, double-blind, placebo …
R Borgohain, J Szasz, M Bhatt, S Rossetti, V Lucini, R Anand
13th International Congress of the Movement Disorder Society, Paris, France …, 2009
62009
Neuroinflammation and microglia/macrophage phenotype modulate the molecular background of post-stroke depression: A literature review
EE Nagy, A Frigy, JA Szász, E Horváth
Experimental and Therapeutic Medicine 20 (3), 2510-2523, 2020
52020
EFFICACY, SAFETY AND PATIENT’S QUALITY OF LIFE OF LONG-TERM TREATMENT WITH LEVODOPA-CARBIDOPA INTESTINAL GEL IN ADVANCED PARKINSON’S DISEASE IN ROMANIA: RESULTS FROM GLORIA …
J Szasz, M Simu, L Perju-Dumbrava, A Antonini, L Bergmann, D Popescu, ...
Romanian Journal of Neurology 19 (1), 2020
52020
The importance of evaluation of gastrointestinal symptoms in advanced Parkinson’s disease
J Szász, S Szatmári, V Constantin, I Mihály, A Rácz, I Török, E Nagy, ...
Orvosi hetilap 161 (39), 1681-1687, 2020
42020
The system can't perform the operation now. Try again later.
Articles 1–20